When preventing a disease is harder than its treatment
Search results for: heparin
A Catalyst for Antiphospholipid Syndrome Research
APS ACTION is coordinating international efforts to study this rare and potentially fatal autoimmune disorder
Drug Updates
Information on News Approvals and Medication Safety
Hypercoagulable States in Rheumatic Disease
Prevention and management strategies continue to evolve
Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is an autoimmune disease associated with frequent clotting in arteries and veins and fetal losses. The clotting results from the presence of proteins in the blood—called antiphospholipid autoantibodies (aPL)—formed against the person’s own tissues.
Drug Safety
What can the ACR do?
A Better Family Plan
How to minimize the risks of pregnancy for women with SLE
Antiphospholipid Antibody Syndrome
A recently identified autoimmune disorder, antiphospholipid antibody syndrome (APS) mainly affects young women between age 30 and 40. Those affected by APS may otherwise be healthy or have an underlying disease such as systemic lupus erythematosus (SLE).
Put Hughes Syndrome on Your Radar
Diagnosis of antiphospholipid syndrome is increasing. Here’s how to recognize and treat it
- « Previous Page
- 1
- …
- 3
- 4
- 5